Preventive Role of Resveratrol Against Inflammatory Cytokines and Related Diseases

Author(s): Tanzir Rafe, Parvez Ahmed Shawon, Liyad Salem, Nafij Imtiyaj Chowdhury, Farjana Kabir, Shah Mehedi Bin Zahur, Rowshon Akhter, Humaira Binte Noor, Md Mohabbulla Mohib, Md. Abu Taher Sagor*.

Journal Name: Current Pharmaceutical Design

Volume 25 , Issue 12 , 2019


Abstract:

Background: Immunity is the ultimate barrier between foreign stimuli and a host cell. Unwanted immune responses can threaten the host cells and may eventually damage a vital organ. Overproduction of inflammatory cytokines may also lead to autoimmune diseases. Inflammatory cells and pro-inflammatory cytokines can eventually progress to renal, cardiac, brain, hepatic, pancreatic and ocular inflammation that can result in severe damage in the long run. Evidence also suggests that inflammation may lead to atherosclerosis, Alzheimer’s, hypertension, stroke, cysts and cancers.

Methods: This study was designed to correlate the possible molecular mechanisms for inflammatory diseases and prevent biochemical changes owing to inflammatory cytokines by using Resveratrol. Therefore, we searched and accumulated very recent literature on inflammatory disorders and Resveratrol. We scoured PubMed, Scopus, Science Direct, PLoS One and Google Scholar to gather papers and related information.

Results: Reports show that inflammatory diseases are very complex, as multiple cascade systems are involved; therefore, they are quite difficult to cure. However, our literature search also correlates some possible molecular interactions by which inflammation can be prevented. We noticed that Resveratrol is a potent lead component and has multiple activities against harmful inflammatory cytokines and related microRNA. Our study also suggests that the anti-inflammatory properties of Resveratrol have been highly studied on animal models, cell lines and human subjects and proven to be very effective in reducing inflammatory cell production and pro-inflammatory cytokine accumulation. Our tables and figures also demonstrate recent findings and possible preventive activities to minimize inflammatory diseases.

Conclusion: This study would outline the role of harmful inflammatory cytokines as well as how they accelerate pathophysiology and progress to an inflammatory disorder. Therefore, this study might show a potential therapeutic value of using Resveratrol by health professionals in preventing inflammatory disorders.

Keywords: Immunity, inflammation, inflammatory disorders, microRNA and resveratrol, cytokines.

[1]
Sagor MAT, Tabassum N, Potol MA, Alam MA. Xanthine oxidase inhibitor, allopurinol, prevented oxidative stress, fibrosis, and myocardial damage in isoproterenol induced aged rats. Oxidat Med Cell Long 2015; 2015: 478039. [http://dx.doi.org/10.1155/2015/478039].
[2]
Abu Taher Sagor M, Mahmud Reza H, Tabassum N, et al. Supplementation of rosemary leaves (Rosmarinus officinalis) powder attenuates oxidative stress, inflammation and fibrosis in carbon tetrachloride (CCl4) treated rats. Curr Nutr Food Sci 2016; 12(4): 288-95. [http://dx.doi.org/10.2174/1573401312666160816154610].
[3]
Luetkens JA, Doerner J, Schwarze-Zander C, et al. Cardiac magnetic resonance reveals signs of subclinical myocardial inflammation in asymptomatic HIV-infected patients. Circ Cardiovasc Imaging 2016; 9(3): e004091. [http://dx.doi.org/10.1161/CIRCIMAGING.115.004091]. [PMID: 26951603].
[4]
Bonavita E, Gentile S, Rubino M, et al. PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer. Cell 2015; 160(4): 700-14. [http://dx.doi.org/10.1016/j.cell.2015.01.004]. [PMID: 25679762].
[5]
Sagor AT, Chowdhury MRH, Tabassum N, Hossain H, Rahman MM, Alam MA. Supplementation of fresh ucche (Momordica charantia L. var. muricata Willd) prevented oxidative stress, fibrosis and hepatic damage in CCl4 treated rats. BMC Complement Altern Med 2015; 15(1): 115. [http://dx.doi.org/10.1186/s12906-015-0636-1]. [PMID: 25884170].
[6]
Marzeea AR, Abida T, Salma K, et al. Inhibitory role of resveratrol in the development of profibrogenesis and fibrosis mechanisms. Immunol Endocr Metab Agents Med Chem 2018; 18(1): 80-104. [http://dx.doi.org/10.2174/1871522218666180523102923].
[7]
Hannan NJ, Brownfoot FC, Cannon P, et al. Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction - implications as a preeclampsia treatment. Sci Rep 2017; 7(1): 1819. [http://dx.doi.org/10.1038/s41598-017-01993-w]. [PMID: 28500309].
[8]
Wu Z, Huang A, Yan J, et al. Resveratrol ameliorates cardiac dysfunction by inhibiting apoptosis via the PI3K/Akt/FoxO3a pathway in a rat model of diabetic cardiomyopathy. J Cardiovasc Pharmacol 2017; 70(3): 184-93. [http://dx.doi.org/10.1097/FJC.0000000000000504]. [PMID: 28678055].
[9]
Ginés C, Cuesta S, Kireev R, et al. Protective effect of resveratrol against inflammation, oxidative stress and apoptosis in pancreas of aged SAMP8 mice. Exp Gerontol 2017; 90: 61-70. [http://dx.doi.org/10.1016/j.exger.2017.01.021]. [PMID: 28130161].
[10]
Alghetaa H, Mohammed A, Sultan M, et al. Resveratrol protects mice against SEB-induced acute lung injury and mortality by miR-193a modulation that targets TGF-β signalling. J Cell Mol Med 2018; 22(5): 2644-55. [http://dx.doi.org/10.1111/jcmm.13542]. [PMID: 29512867].
[11]
Ahmad SF, Ansari MA, Nadeem A, Alzahrani MZ, Bakheet SA, Attia SM. Resveratrol improves neuroimmune dysregulation through the inhibition of neuronal toll-like receptors and COX-2 signaling in BTBR T+ Itpr3tf/J mice. Neuromolecular Med 2018; 20(1): 133-46. [http://dx.doi.org/10.1007/s12017-018-8483-0]. [PMID: 29468499].
[12]
Palomera-Ávalos V, Griñán-Ferré C, Izquierdo V, et al. Resveratrol modulates response against acute inflammatory stimuli in aged mouse brain. Exp Gerontol 2018; 102: 3-11. [http://dx.doi.org/10.1016/j.exger.2017.11.014]. [PMID: 29174969].
[13]
Xu M, Cheng Z, Ding Z, Wang Y, Guo Q, Huang C. Resveratrol enhances IL-4 receptor-mediated anti-inflammatory effects in spinal cord and attenuates neuropathic pain following sciatic nerve injury. Mol Pain 2018; 141744806918767549. [http://dx.doi.org/10.1177/1744806918767549]. [PMID: 29592782].
[14]
Akbel E, Arslan-Acaroz D, Demirel HH, Kucukkurt I, Ince S. The subchronic exposure to malathion, an organophosphate pesticide, causes lipid peroxidation, oxidative stress, and tissue damage in rats: the protective role of resveratrol. Toxicol Res (Camb) 2018; 7(3): 503-12. [http://dx.doi.org/10.1039/C8TX00030A]. [PMID: 30090600].
[15]
Meng Q, Guo T, Li G, et al. Dietary resveratrol improves antioxidant status of sows and piglets and regulates antioxidant gene expression in placenta by Keap1-Nrf2 pathway and Sirt1. J Anim Sci Biotechnol 2018; 9(1): 34. [http://dx.doi.org/10.1186/s40104-018-0248-y]. [PMID: 29713468].
[16]
Rossi EL, Khatib SA, Doerstling SS, et al. Resveratrol inhibits obesity-associated adipose tissue dysfunction and tumor growth in a mouse model of postmenopausal claudin-low breast cancer. Mol Carcinog 2018; 57(3): 393-407. [http://dx.doi.org/10.1002/mc.22763]. [PMID: 29197120].
[17]
Hajipour E, Mashayekhi FJ, Mosayebi G, Baazm M, Zendedel A. Resveratrol decreases apoptosis and NLRP3 complex expressions in experimental varicocele rat model. Iran J Basic Med Sci 2018; 21(2): 225-9. [PMID: 29456821].
[18]
Al-Hussaini H, Kilarkaje N. Trans-resveratrol mitigates type 1 diabetes-induced oxidative DNA damage and accumulation of advanced glycation end products in glomeruli and tubules of rat kidneys. Toxicol Appl Pharmacol 2018; 339: 97-109. [http://dx.doi.org/10.1016/j.taap.2017.11.025]. [PMID: 29229234].
[19]
Ikeda E, Ikeda Y, Wang Y, et al. Resveratrol derivative-rich melinjo seed extract induces healing in a murine model of established periodontitis. J Periodontol 2018; 89(5): 586-95. [http://dx.doi.org/10.1002/JPER.17-0352]. [PMID: 29856488].
[20]
Liu S, Zheng Z, Ji S, et al. Resveratrol reduces senescence-associated secretory phenotype by SIRT1/NF-κB pathway in gut of the annual fish Nothobranchius guentheri. Fish Shellfish Immunol 2018; 80: 473-9. [http://dx.doi.org/10.1016/j.fsi.2018.06.027]. [PMID: 29908321].
[21]
Roberts VH, Pound LD, Thorn SR, et al. Beneficial and cautionary outcomes of resveratrol supplementation in pregnant nonhuman primates. FASEB J 2014; 28(6): 2466-77. [http://dx.doi.org/10.1096/fj.13-245472]. [PMID: 24563374].
[22]
Vors C, Couillard C, Paradis M-E, et al. Supplementation with resveratrol and curcumin does not affect the inflammatory response to a high-fat meal in older adults with abdominal obesity: A randomized, placebo-controlled crossover trial. J Nutr 2018; 148(3): 379-88. [http://dx.doi.org/10.1093/jn/nxx072]. [PMID: 29546309].
[23]
Lee CT, Chang LC, Liu CW, Wu PF. Negative correlation between serum uric acid and kidney URAT1 mRNA expression caused by resveratrol in rats. Mol Nutr Food Res 2017; 61(10): 1601030. [http://dx.doi.org/10.1002/mnfr.201601030]. [PMID: 28499081].
[24]
Kjær TN, Ornstrup MJ, Poulsen MM, et al. No beneficial effects of resveratrol on the metabolic syndrome: a randomized placebo-controlled clinical trial. J Clin Endocrinol Metab 2017; 102(5): 1642-51. [http://dx.doi.org/10.1210/jc.2016-2160]. [PMID: 28182820].
[25]
Zheng S, Feng Q, Cheng J, Zheng J. Maternal resveratrol consumption and its programming effects on metabolic health in offspring mechanisms and potential implications. Biosci Rep 2018; 38(2): BSR20171741. [http://dx.doi.org/10.1042/BSR20171741]. [PMID: 29437902].
[26]
Berman AY, Motechin RA, Wiesenfeld MY, Holz MK. The therapeutic potential of resveratrol: A review of clinical trials. NPJ Precis Oncol 2017; 1(1): 35.
[http://dx.doi.org/10.1038/s41698-017-0038-6]
[27]
Han YS, Penthala NR, Oliveira M, et al. Identification of resveratrol analogs as potent anti-dengue agents using a cell-based assay. J Med Virol 2017; 89(3): 397-407. [http://dx.doi.org/10.1002/jmv.24660]. [PMID: 27509184].
[28]
Giuliani C, Iezzi M, Ciolli L, et al. Resveratrol has anti-thyroid effects both in vitro and in vivo. Food Chem Toxicol 2017; 107(Pt A). : 237-47. [http://dx.doi.org/10.1016/j.fct.2017.06.044] [PMID: 28668442].
[29]
Magyar K, Halmosi R, Palfi A, et al. Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease. Clin Hemorheol Microcirc 2012; 50(3): 179-87. [PMID: 22240353].
[30]
Opipari AW Jr, Tan L, Boitano AE, Sorenson DR, Aurora A, Liu JR. Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res 2004; 64(2): 696-703. [http://dx.doi.org/10.1158/0008-5472.CAN-03-2404]. [PMID: 14744787].
[31]
Mueller SO, Simon S, Chae K, Metzler M, Korach KS. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor α (ERalpha) and ERbeta in human cells. Toxicol Sci 2004; 80(1): 14-25. [http://dx.doi.org/10.1093/toxsci/kfh147]. [PMID: 15084758].
[32]
Otsuka K, Yamamoto Y, Ochiya T. Regulatory role of resveratrol, a microRNA-controlling compound, in HNRNPA1 expression, which is associated with poor prognosis in breast cancer. Oncotarget 2018; 9(37): 24718-30. [http://dx.doi.org/10.18632/oncotarget.25339]. [PMID: 29872500].
[33]
Shen L, Ji H-F. Reciprocal interactions between resveratrol and gut microbiota deepen our understanding of molecular mechanisms underlying its health benefits. Trends Food Sci Technol 2018; 81: 232-6. [http://dx.doi.org/10.1016/j.tifs.2018.09.026].
[34]
Wu F, Cui L. Resveratrol suppresses melanoma by inhibiting NF-κB/miR-221 and inducing TFG expression. Arch Dermatol Res 2017; 309(10): 823-31. [http://dx.doi.org/10.1007/s00403-017-1784-6]. [PMID: 28936555].
[35]
Alam P, Raka MA, Khan S, et al. A clinical review of the effectiveness of tomato (Solanum lycopersicum) against cardiovascular dysfunction and related metabolic syndrome. J Herb Med 2018. [http://dx.doi.org/10.1016/j.hermed.2018.09.006].
[36]
Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323(4): 236-41. [http://dx.doi.org/10.1056/NEJM199007263230405]. [PMID: 2195340].
[37]
Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999; 340(2): 115-26. [http://dx.doi.org/10.1056/NEJM199901143400207]. [PMID: 9887164].
[38]
Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circ Res 2012; 110(1): 159-73. [http://dx.doi.org/10.1161/CIRCRESAHA.111.243162]. [PMID: 22223212].
[39]
Frangogiannis NG. The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities. J Cardiovasc Pharmacol 2014; 63(3): 185-95. [http://dx.doi.org/10.1097/FJC.0000000000000003]. [PMID: 24072174].
[40]
Ueland T, Gullestad L, Nymo SH, Yndestad A, Aukrust P, Askevold ET. Inflammatory cytokines as biomarkers in heart failure. Clin Chim Acta 2015; 443: 71-7. [http://dx.doi.org/10.1016/j.cca.2014.09.001]. [PMID: 25199849].
[41]
Peters MJ, Symmons DP, McCarey D, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010; 69(2): 325-31. [http://dx.doi.org/10.1136/ard.2009.113696]. [PMID: 19773290].
[42]
Alam MA, Chowdhury MRH, Jain P, Sagor MAT, Reza HM. DPP-4 inhibitor sitagliptin prevents inflammation and oxidative stress of heart and kidney in two kidney and one clip (2K1C) rats. Diabetol Metab Syndr 2015; 7(1): 107. [http://dx.doi.org/10.1186/s13098-015-0095-3]. [PMID: 26609328].
[43]
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365(9455): 217-23. [http://dx.doi.org/10.1016/S0140-6736(05)70151-3]. [PMID: 15652604].
[44]
Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet 2017; 389(10075): 1238-52. [http://dx.doi.org/10.1016/S0140-6736(16)32064-5]. [PMID: 27887750].
[45]
Sagor MAT, Rabbi MG, Rahman MM, et al. Chronic kidney disease might lead to hepatic dysfunction on a chronic hypertensive rat model study. World J Pharm Res 2015; 4(11): 1939-56.
[46]
Scrascia G, Rotunno C, Simone S, et al. Acute kidney injury in high-risk cardiac surgery patients: roles of inflammation and coagulation. J Cardiovasc Med (Hagerstown) 2017; 18(5): 359-65. [http://dx.doi.org/10.2459/JCM.0000000000000343]. [PMID: 26657082].
[47]
Sagor MAT, Mohib MM, Azam MS, et al. Angiotensin-II, a potent peptide, participates in the development of hepatic dysfunctions. Immunol Endocr Metab Agents Med Chem 2016; 16(3): 161-77.
[48]
Tacke F. New insights on the role of kupffer cells in liver transplantation. Transplantation 2018; 102(6): 896-7. [http://dx.doi.org/10.1097/TP.0000000000002193]. [PMID: 29570168].
[49]
Szabo G, Mandrekar P, Dolganiuc A. Innate immune response and hepatic inflammation.Seminars in liver disease: 2007: © Thieme Medical Publishers 2007; 339-50.
[http://dx.doi.org/10.1055/s-2007-991511]
[50]
Chowdhury MRH, Sagor MAT, Tabassum N, Potol MA, Hossain H, Alam MA. Supplementation of Citrus maxima peel powder prevented oxidative stress, fibrosis, and hepatic damage in carbon tetrachloride (CCl4) treated rats. Evid-Based Comp Altern Med 2015; 2015: 598179.
[51]
Mohib MM, Afnan K, Paran TZ, et al. Beneficial role of citrus fruit polyphenols against hepatic dysfunctions: A review. J Diet Suppl 2017; 15(2): 1-29. [PMID: 28641051].
[52]
Sagor MAT, Mohib M, Tabassum N, Ahmed I, Reza H. Fresh seed supplementation of Syzygium cumini attenuated oxidative stress, inflammation, fibrosis, iron overload, hepatic dysfunction and renal injury in acetaminophen induced rats. J Drug Metab Toxicol 2016; 7(2)
[53]
Raraty MG, Murphy JA, Mcloughlin E, Smith D, Criddle D, Sutton R. Mechanisms of acinar cell injury in acute pancreatitis. Scand J Surg 2005; 94(2): 89-96. [http://dx.doi.org/10.1177/145749690509400202]. [PMID: 16111088].
[54]
Szatmary P, Gukovsky I. The Role of Cytokines and Inflammation in the Genesis of Experimental Pancreatitis Pancreapedia. The Exocrine Pancreas Knowledge Base 2016.
[55]
Waldron RT, Pandol S, Lugea A, Groblewski G. Endoplasmic Reticulum Stress and the Unfolded Protein Response in Exocrine Pancreas Physiology and Pancreatitis.Pancreatitis. edn.: Pancreapedia: Exocrine Pancreas Knowledge Base Mountain View, CA 2015; 88-96.
[56]
Balakrishnan V, Rajesh G. Chronic pancreatitis. Pract Gastroenterol 2016; 175.
[57]
Chakraborty S, Kaushik DK, Gupta M, Basu A. Inflammasome signaling at the heart of central nervous system pathology. J Neurosci Res 2010; 88(8): 1615-31. [http://dx.doi.org/10.1002/jnr.22343]. [PMID: 20127816].
[58]
Singhal G, Jaehne EJ, Corrigan F, Toben C, Baune BT. Inflammasomes in neuroinflammation and changes in brain function: a focused review. Front Neurosci 2014; 8: 315. [http://dx.doi.org/10.3389/fnins.2014.00315]. [PMID: 25339862].
[59]
Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005; 57(1): 67-81. [http://dx.doi.org/10.1002/ana.20315]. [PMID: 15546155].
[60]
van Harten AE, Scheeren TW, Absalom AR. A review of postoperative cognitive dysfunction and neuroinflammation associated with cardiac surgery and anaesthesia. Anaesthesia 2012; 67(3): 280-93. [http://dx.doi.org/10.1111/j.1365-2044.2011.07008.x]. [PMID: 22321085].
[61]
Stephenson J, Nutma E, van der Valk P, Amor S. Inflammation in CNS neurodegenerative diseases. Immunology 2018; 154(2): 204-19. [http://dx.doi.org/10.1111/imm.12922]. [PMID: 29513402].
[62]
Motwani MP, Bennett F, Norris PC, et al. Potent anti‐inflammatory and pro‐resolving effects of anabasum in a human model of self‐resolving acute inflammation. Clin Pharmacol Ther 2018; 104(4): 675-86. [PMID: 29238967].
[63]
Kushner I. The phenomenon of the acute phase response. Ann N Y Acad Sci 1982; 389(1): 39-48. [http://dx.doi.org/10.1111/j.1749-6632.1982.tb22124.x]. [PMID: 7046585].
[64]
Elshaer M, Chen Y, Wang XJ, Tang X. Resveratrol: An overview of its anti-cancer mechanisms. Life Sci 2018; 207: 340-9. [http://dx.doi.org/10.1016/j.lfs.2018.06.028]. [PMID: 29959028].
[65]
Niess H, Camaj P, Renner A, et al. Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis. Target Oncol 2015; 10(2): 215-27. [http://dx.doi.org/10.1007/s11523-014-0323-z]. [PMID: 24950733].
[66]
Chai EZP, Siveen KS, Shanmugam MK, Arfuso F, Sethi G. Analysis of the intricate relationship between chronic inflammation and cancer. Biochem J 2015; 468(1): 1-15. [http://dx.doi.org/10.1042/BJ20141337]. [PMID: 25940732].
[67]
Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature 2017; 541(7637): 321-30. [http://dx.doi.org/10.1038/nature21349]. [PMID: 28102259].
[68]
Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res 2014; 2014: 149185. [http://dx.doi.org/10.1155/2014/149185].
[69]
Pang MF, Georgoudaki AM, Lambut L, et al. TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis. Oncogene 2016; 35(6): 748-60. [http://dx.doi.org/10.1038/onc.2015.133]. [PMID: 25961925].
[70]
Baldwin AS Jr. The NF-κ B and I κ B proteins: new discoveries and insights. Annu Rev Immunol 1996; 14(1): 649-83. [http://dx.doi.org/10.1146/annurev.immunol.14.1.649]. [PMID: 8717528].
[71]
Chiang M-C, Nicol CJ, Cheng Y-C. Resveratrol activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against amyloid-beta-induced inflammation and oxidative stress. Neurochem Int 2018; 115: 1-10. [http://dx.doi.org/10.1016/j.neuint.2017.10.002]. [PMID: 28989083].
[72]
Zhao H, Wang Q, Cheng X, et al. Inhibitive effect of resveratrol on the inflammation in cultured astrocytes and microglia induced by Aβ1-42. Neuroscience 2018; 379: 390-404. [http://dx.doi.org/10.1016/j.neuroscience.2018.03.047]. [PMID: 29627302].
[73]
Arbabi S, Maier RV. Mitogen-activated protein kinases. Crit Care Med 2002; 30(1): S74-9. [http://dx.doi.org/10.1097/00003246-200201001-00010].
[74]
Mohib MM, Hasan I, Chowdhury WK, et al. Role of angiotensin ii in hepatic inflammation through MAPK pathway: A review. J Hepatol 2016; 2(2): 13.
[75]
Chang C, Zhao Y, Song G, She K. Resveratrol protects hippocampal neurons against cerebral ischemia-reperfusion injury via modulating JAK/ERK/STAT signaling pathway in rats. J Neuroimmunol 2018; 315: 9-14. [http://dx.doi.org/10.1016/j.jneuroim.2017.11.015]. [PMID: 29306408].
[76]
Hu W, Yang E, Ye J, Han W, Du ZL. Resveratrol protects neuronal cells from isoflurane-induced inflammation and oxidative stress-associated death by attenuating apoptosis via Akt/p38 MAPK signaling. Exp Ther Med 2018; 15(2): 1568-73. [PMID: 29434742].
[77]
Yao Y, Liu K, Zhao Y, Hu X, Wang M. Pterostilbene and 4′-methoxyresveratrol inhibited lipopolysaccharide-induced inflammatory response in RAW264.7 Macrophages. Molecules 2018; 23(5): 1148. [http://dx.doi.org/10.3390/molecules23051148]. [PMID: 29751609].
[78]
Mohib MM, Rabby SF, Paran TZ, et al. Protective role of green tea on diabetic nephropathy-A review. Cogent Biol 2016; 2(1): 1248166.
[79]
Thompson MD, Monga SP. WNT/β-catenin signaling in liver health and disease. Hepatology 2007; 45(5): 1298-305. [http://dx.doi.org/10.1002/hep.21651]. [PMID: 17464972].
[80]
Hoeppner LH, Secreto FJ, Westendorf JJ. Wnt signaling as a therapeutic target for bone diseases. Expert Opin Ther Targets 2009; 13(4): 485-96. [http://dx.doi.org/10.1517/14728220902841961]. [PMID: 19335070].
[81]
Bourguignon LY, Xia W, Wong G. Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates β-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells. J Biol Chem 2009; 284(5): 2657-71. [http://dx.doi.org/10.1074/jbc.M806708200]. [PMID: 19047049].
[82]
Xu S, Sun F, Ren L, Yang H, Tian N, Peng S. Resveratrol controlled the fate of porcine pancreatic stem cells through the Wnt/β-catenin signaling pathway mediated by Sirt1. PLoS One 2017; 12(10): e0187159. [http://dx.doi.org/10.1371/journal.pone.0187159]. [PMID: 29073244].
[83]
Liu S, Yang H, Hu B, Zhang M. Sirt1 regulates apoptosis and extracellular matrix degradation in resveratrol-treated osteoarthritis chondrocytes via the Wnt/β-catenin signaling pathways. Exp Ther Med 2017; 14(5): 5057-62. [http://dx.doi.org/10.3892/etm.2017.5165]. [PMID: 29201214].
[84]
Li C, Wu W, Jiao G, Chen Y, Liu H. Resveratrol attenuates inflammation and reduces matrix-metalloprotease expression by inducing autophagy via suppressing the Wnt/β-catenin signaling pathway in IL-1β-induced osteoarthritis chondrocytes. RSC Advances 2018; 8(36): 20202-10. [http://dx.doi.org/10.1039/C8RA00993G].
[85]
Seyyedsalehi MS, Saboor-Yaraghi AA, Koohdani F, et al. Resveratrol inhibits Wnt-signaling by affecting β-catenin and GSK-3β gene expression in HCT-116 human colorectal cancer cells Basic &. Clin Cancer Res 2018.
[86]
Cilibrasi C, Riva G, Romano G, et al. Resveratrol impairs glioma stem cells proliferation and motility by modulating the wnt signaling pathway. PLoS One 2017; 12(1): e0169854. [http://dx.doi.org/10.1371/journal.pone.0169854]. [PMID: 28081224].
[87]
Liu H, Shen J, Zhou H, Xu S, Hu Z. Resveratrol regulate the extracellular matrix expression via Wnt/β-catenin pathway in nucleus pulposus cells]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2018; 32(4): 476-83. [PMID: 29806307]
[88]
Palomera-Avalos V, Griñán-Ferré C, Puigoriol-Ilamola D, et al. Resveratrol protects SAMP8 brain under metabolic stress: focus on mitochondrial function and Wnt pathway. Mol Neurobiol 2017; 54(3): 1661-76. [http://dx.doi.org/10.1007/s12035-016-9770-0]. [PMID: 26873850].
[89]
Kulkarni AB, Huh C-G, Becker D, et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993; 90(2): 770-4. [http://dx.doi.org/10.1073/pnas.90.2.770]. [PMID: 8421714].
[90]
Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998; 101(4): 890-8. [http://dx.doi.org/10.1172/JCI1112]. [PMID: 9466984].
[91]
Razali N, Agarwal R, Agarwal P, Froemming GRA, Tripathy M, Ismail NM. IOP lowering effect of topical trans-resveratrol involves adenosine receptors and TGF-β2 signaling pathways. Eur J Pharmacol 2018; 838: 1-10. [http://dx.doi.org/10.1016/j.ejphar.2018.08.035]. [PMID: 30171854].
[92]
Qiao Y, Gao K, Wang Y, Wang X, Cui B. Resveratrol ameliorates diabetic nephropathy in rats through negative regulation of the p38 MAPK/TGF-β1 pathway. Exp Ther Med 2017; 13(6): 3223-30. [http://dx.doi.org/10.3892/etm.2017.4420]. [PMID: 28588674].
[93]
Abed É, Delalandre A, Lajeunesse D. Beneficial effect of resveratrol on phenotypic features and activity of osteoarthritic osteoblasts. Arthritis Res Ther 2017; 19(1): 151. [http://dx.doi.org/10.1186/s13075-017-1365-2]. [PMID: 28666466].
[94]
Chen J, Cao X, Cui Y, Zeng G, Chen J, Zhang G. Resveratrol alleviates lysophosphatidylcholine-induced damage and inflammation in vascular endothelial cells. Mol Med Rep 2018; 17(3): 4011-8. [PMID: 29257345].
[95]
Zunino SJ, Hwang DH, Huang S, Storms DH. Resveratrol increases phagocytosis and lipopolysaccharide-induced interleukin-1β production, but decreases surface expression of Toll-like receptor 2 in THP-1 monocytes. Cytokine 2018; 102: 141-4. [http://dx.doi.org/10.1016/j.cyto.2017.07.023]. [PMID: 28800925].
[96]
Sun J, Zhang M, Chen K, et al. Suppression of TLR4 activation by resveratrol is associated with STAT3 and Akt inhibition in oxidized low-density lipoprotein-activated platelets. Eur J Pharmacol 2018; 836: 1-10. [http://dx.doi.org/10.1016/j.ejphar.2018.08.014]. [PMID: 30107164].
[97]
Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001; 11(9): 372-7. [http://dx.doi.org/10.1016/S0962-8924(01)02064-5]. [PMID: 11514191].
[98]
Shi D-D, Dong CM, Ho LC, et al. Resveratrol, a natural polyphenol, prevents chemotherapy-induced cognitive impairment: Involvement of cytokine modulation and neuroprotection. Neurobiol Dis 2018; 114: 164-73. [http://dx.doi.org/10.1016/j.nbd.2018.03.006]. [PMID: 29534932].
[99]
Peñalver P, Belmonte-Reche E, Adán N, et al. Alkylated resveratrol prodrugs and metabolites as potential therapeutics for neurodegenerative diseases. Eur J Med Chem 2018; 146: 123-38. [http://dx.doi.org/10.1016/j.ejmech.2018.01.037]. [PMID: 29407944].
[100]
Palomera-Ávalos V, Griñán-Ferré C, Izquierdo V, Camins A, Sanfeliu C, Pallàs M. Metabolic stress induces cognitive disturbances and inflammation in aged mice: protective role of resveratrol. Rejuvenation Res 2017; 20(3): 202-17. [http://dx.doi.org/10.1089/rej.2016.1885]. [PMID: 27998210].
[101]
Cui Q, Fu Q, Zhao X, et al. Protective effects and immunomodulation on piglets infected with rotavirus following resveratrol supplementation. PLoS One 2018; 13(2): e0192692. [http://dx.doi.org/10.1371/journal.pone.0192692]. [PMID: 29466421].
[102]
Wei Y, Jia J, Jin X, Tong W, Tian H. Resveratrol ameliorates inflammatory damage and protects against osteoarthritis in a rat model of osteoarthritis. Mol Med Rep 2018; 17(1): 1493-8. [PMID: 29138829].
[103]
Cao G, Fan J, Yu H, Chen Z. Resveratrol attenuates high glucose-induced cardiomyocytes injury via interfering ROS-MAPK-NF-κB signaling pathway. Int J Clin Exp Pathol 2018; 11(1): 48.
[104]
Axtell RC, Raman C, Steinman L. Interferon-β exacerbates Th17-mediated inflammatory disease. Trends Immunol 2011; 32(6): 272-7. [http://dx.doi.org/10.1016/j.it.2011.03.008]. [PMID: 21530402].
[105]
Ahmad SF, Ansari MA, Nadeem A, et al. Resveratrol attenuates pro-inflammatory cytokines and activation of JAK1-STAT3 in BTBR T+ Itpr3tf/J autistic mice. Eur J Pharmacol 2018; 829: 70-8. [http://dx.doi.org/10.1016/j.ejphar.2018.04.008]. [PMID: 29654783].
[106]
Fu Q, Cui Q, Yang Y, et al. Effect of resveratrol dry suspension on immune function of piglets. Evid Based Complement Alternat Med 2018; 2018: 5952707. [http://dx.doi.org/10.1155/2018/5952707].
[107]
Zhang H, Yan H, Ying J, et al. Resveratrol ameliorates ionizing irradiation-induced long-term immunosuppression in mice. Int J Radiat Biol 2018; 94(1): 28-36. [http://dx.doi.org/10.1080/09553002.2018.1408976]. [PMID: 29185834].
[108]
Schreiber S, Rosenstiel P, Hampe J, et al. Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease. Gut 2002; 51(3): 379-85. [http://dx.doi.org/10.1136/gut.51.3.379]. [PMID: 12171960].
[109]
Sasaki A, Yasukawa H, Suzuki A, et al. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells 1999; 4(6): 339-51. [http://dx.doi.org/10.1046/j.1365-2443.1999.00263.x]. [PMID: 10421843].
[110]
Suh J, Kim D-H, Surh Y-J. Resveratrol suppresses migration, invasion and stemness of human breast cancer cells by interfering with tumor-stromal cross-talk. Arch Biochem Biophys 2018; 643: 62-71. [http://dx.doi.org/10.1016/j.abb.2018.02.011]. [PMID: 29477771].
[111]
McIlwain DR, Berger T, Mak TW. Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol 2013; 5(4): a008656. [http://dx.doi.org/10.1101/cshperspect.a008656]. [PMID: 23545416].
[112]
Wang Y, Wang X, Zhang L, Zhang R. Alleviation of acute lung injury in rats with sepsis by resveratrol via the phosphatidylinositol 3-kinase/nuclear factor-erythroid 2 related factor 2/heme oxygenase-1 (PI3K/Nrf2/HO-1) pathway. Med Sci Monit 2018; 24: 3604-11. [http://dx.doi.org/10.12659/MSM.910245]. [PMID: 29844304].
[113]
Li J, Li L, Wang S, et al. Resveratrol alleviates inflammatory responses and oxidative stress in rat kidney ischemia-reperfusion injury and H2O2-induced NRK-52E cells via the Nrf2/TLR4/NF-κB pathway. Cell Physiol Biochem 2018; 45(4): 1677-89. [http://dx.doi.org/10.1159/000487735]. [PMID: 29490296].
[114]
Wang X, Zhang Y. Resveratrol alleviates LPS-induced injury in human keratinocyte cell line HaCaT by up-regulation of miR-17. Biochem Biophys Res Commun 2018; 501(1): 106-12. [http://dx.doi.org/10.1016/j.bbrc.2018.04.184]. [PMID: 29704506].
[115]
Willoughby DA, Moore AR, Colville-Nash PR. COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease. Lancet 2000; 355(9204): 646-8. [http://dx.doi.org/10.1016/S0140-6736(99)12031-2]. [PMID: 10696997].
[116]
Papafili A, Hill MR, Brull DJ, et al. Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol 2002; 22(10): 1631-6. [http://dx.doi.org/10.1161/01.ATV.0000030340.80207.C5]. [PMID: 12377741].
[117]
Lee I-T, Yang C-M. Inflammatory signalings involved in airway and pulmonary diseases. Mediators Inflamm 2013; 2013: 791231. [http://dx.doi.org/10.1155/2013/791231].
[118]
Zhang Z, Chen N, Liu JB, et al. Protective effect of resveratrol against acute lung injury induced by lipopolysaccharide via inhibiting the myd88-dependent Toll-like receptor 4 signaling pathway. Mol Med Rep 2014; 10(1): 101-6. [http://dx.doi.org/10.3892/mmr.2014.2226]. [PMID: 24818579].
[119]
Tsai M-H, Hsu L-F, Lee C-W, et al. Resveratrol inhibits urban particulate matter-induced COX-2/PGE2 release in human fibroblast-like synoviocytes via the inhibition of activation of NADPH oxidase/ROS/NF-κB. Int J Biochem Cell Biol 2017; 88: 113-23. [http://dx.doi.org/10.1016/j.biocel.2017.05.015]. [PMID: 28495310].
[120]
Zhang Y, Lu Y, Ong’achwa MJ, et al. Resveratrol inhibits the TGF-β1-induced proliferation of cardiac fibroblasts and collagen secretion by downregulating miR-17 in Rat. BioMed Res Int 2018; 2018: 8730593.
[121]
Kadhim S, Singh NP, Zumbrun EE, et al. Resveratrol-mediated attenuation of Staphylococcus aureus enterotoxin B-induced acute liver injury is associated with regulation of microRNA and induction of Myeloid-derived Suppressor Cells. Front Microbiol 2018; 9: 2910. [http://dx.doi.org/10.3389/fmicb.2018.02910]. [PMID: 30619104].
[122]
Al Aameri RFH, Sheth S, Alanisi EMA, et al. Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: Reversal by resveratrol. PLoS One 2017; 12(5): e0177198. [http://dx.doi.org/10.1371/journal.pone.0177198]. [PMID: 28467474].
[123]
Wang J, He F, Chen L, et al. Resveratrol inhibits pulmonary fibrosis by regulating miR-21 through MAPK/AP-1 pathways. Biomed Pharmacother 2018; 105: 37-44. [http://dx.doi.org/10.1016/j.biopha.2018.05.104]. [PMID: 29843043].
[124]
Xin Y, Zhang H, Jia Z, et al. Resveratrol improves uric acid-induced pancreatic β-cells injury and dysfunction through regulation of miR-126. Biomed Pharmacother 2018; 102: 1120-6. [http://dx.doi.org/10.1016/j.biopha.2018.03.172]. [PMID: 29710530].
[125]
Liu G, Li H, Yang F, et al. Role of resveratrol and miRNA-126 in vascular endothelial cells of hypertensive rats. Biomed Res 2017; 28(8)
[126]
Zeng K, Wang Y, Yang N, et al. Resveratrol inhibits diabetic-induced Müller cells apoptosis through microRNA-29b/specificity protein 1 pathway. Mol Neurobiol 2017; 54(6): 4000-14. [http://dx.doi.org/10.1007/s12035-016-9972-5]. [PMID: 27311771].
[127]
Venkatadri R, Muni T, Iyer AK, Yakisich JS, Azad N. Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death. Cell Death Dis 2016; 7(2): e2104. [http://dx.doi.org/10.1038/cddis.2016.6]. [PMID: 26890143].
[128]
Yan B, Cheng L, Jiang Z, et al. Resveratrol inhibits ROS-promoted activation and glycolysis of pancreatic stellate cells via suppression of miR-21. Oxid Med Cell Long 2018; 2018: 1346958.
[129]
Dao TT, Ha DT, Hien TT, et al. Resveratrol suppressed lps-induced cox-2 VIA miR-146a-5p inhibition in raw246. 7 cells. Farmacia 2017; 65(2): 214-8.
[130]
Karimi Dermani F, Saidijam M, Amini R, Mahdavinezhad A, Heydari K, Najafi R. Resveratrol inhibits proliferation, invasion, and epithelial-mesenchymal transition by increasing miR-200c expression in HCT-116 colorectal cancer cells. J Cell Biochem 2017; 118(6): 1547-55. [http://dx.doi.org/10.1002/jcb.25816]. [PMID: 27918105].
[131]
Ma C, Wang Y, Shen A, Cai W. Resveratrol upregulates SOCS1 production by lipopolysaccharide-stimulated RAW264.7 macrophages by inhibiting miR-155. Int J Mol Med 2017; 39(1): 231-7. [http://dx.doi.org/10.3892/ijmm.2016.2802]. [PMID: 28004106].
[132]
Soskić SS, Dobutović BD, Sudar EM, et al. Regulation of inducible nitric oxide synthase (iNOS) and its potential role in insulin resistance, diabetes and heart failure. Open Cardiovasc Med J 2011; 5: 153-63. [http://dx.doi.org/10.2174/1874192401105010153]. [PMID: 21792376].
[133]
Downey D, Elborn JS. Nitric oxide, iNOS, and inflammation in cystic fibrosis. J Pathol 2000; 190(2): 115-6. [http://dx.doi.org/10.1002/(SICI)1096-9896(200002)190:2<115:AID-PATH491>3.0.CO;2-V]. [PMID: 10657007].
[134]
Agustí A, Morlá M, Sauleda J, Saus C, Busquets X. NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thorax 2004; 59(6): 483-7. [http://dx.doi.org/10.1136/thx.2003.017640]. [PMID: 15170030].
[135]
Chung HY, Kim HJ, Kim JW, Yu BP. The inflammation hypothesis of aging: molecular modulation by calorie restriction. Ann N Y Acad Sci 2001; 928(1): 327-35. [http://dx.doi.org/10.1111/j.1749-6632.2001.tb05662.x]. [PMID: 11795524].
[136]
Volti GL, Sorrenti V, Murabito P, et al. Pharmacological induction of heme oxygenase-1 inhibits iNOS and oxidative stress in renal ischemia-reperfusion injury. Transplantation proceedings: 2007 Elsevier 2007; 2986-91.
[http://dx.doi.org/10.1016/j.transproceed.2007.09.047]
[137]
del Zoppo G, Ginis I, Hallenbeck JM, Iadecola C, Wang X, Feuerstein GZ. Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol 2000; 10(1): 95-112. [http://dx.doi.org/10.1111/j.1750-3639.2000.tb00247.x]. [PMID: 10668900].
[138]
Wiedemann J, Rashid K, Langmann T. Resveratrol induces dynamic changes to the microglia transcriptome, inhibiting inflammatory pathways and protecting against microglia-mediated photoreceptor apoptosis. Biochem Biophys Res Commun 2018; 501(1): 239-45. [http://dx.doi.org/10.1016/j.bbrc.2018.04.223]. [PMID: 29723528].
[139]
Elbe H, Gul M, Cetin A, et al. Resveratrol reduces light and electron microscopic changes in acetaminophen-induced hepatotoxicity in rats: Role of iNOS expression. Ultrastruct Pathol 2018; 42(1): 39-48. [http://dx.doi.org/10.1080/01913123.2017.1374313]. [PMID: 29192844].
[140]
Tiao M-M, Lin Y-J, Yu H-R, et al. Resveratrol ameliorates maternal and post-weaning high-fat diet-induced nonalcoholic fatty liver disease via renin-angiotensin system. Lipids Health Dis 2018; 17(1): 178. [http://dx.doi.org/10.1186/s12944-018-0824-3]. [PMID: 30055626].
[141]
Kim EN, Kim MY, Lim JH, et al. The protective effect of resveratrol on vascular aging by modulation of the renin-angiotensin system. Atherosclerosis 2018; 270: 123-31. [http://dx.doi.org/10.1016/j.atherosclerosis.2018.01.043]. [PMID: 29407880].
[142]
Dorri Mashhadi F, Zavvar Reza J, Jamhiri M, Hafizi Z, Zare Mehrjardi F, Safari F. The effect of resveratrol on angiotensin II levels and the rate of transcription of its receptors in the rat cardiac hypertrophy model. J Physiol Sci 2017; 67(2): 303-9. [http://dx.doi.org/10.1007/s12576-016-0465-0]. [PMID: 27324786].
[143]
Ge L, Li C, Wang Z, Zhang Y, Chen L. Suppression of oxidative stress and apoptosis in electrically stimulated neonatal rat cardiomyocytes by resveratrol and underlying mechanisms. J Cardiovasc Pharmacol 2017; 70(6): 396-404. [http://dx.doi.org/10.1097/FJC.0000000000000534]. [PMID: 28857948].
[144]
Halliwell B. Free radicals and antioxidants - quo vadis? Trends Pharmacol Sci 2011; 32(3): 125-30. [http://dx.doi.org/10.1016/j.tips.2010.12.002]. [PMID: 21216018].
[145]
Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 2009; 8(7): 579-91. [http://dx.doi.org/10.1038/nrd2803]. [PMID: 19478820].
[146]
Sagor MAT, Reza HM, Tabassum N, Rahman MM, Alam MA. Fresh bitter melon fruit (Momordica charantia) attenuated oxidative stress, fibrosis and renal injury in carbon tetrachloride treated rats. Dhaka Univ J Pharm Sci 2018; 16(2): 205-14. [http://dx.doi.org/10.3329/dujps.v16i2.35258].
[147]
Alam MA, Sagor AT, Tabassum N, et al. Caffeic acid rich Citrus macroptera peel powder supplementation prevented oxidative stress, fibrosis and hepatic damage in CCl 4 treated rats. Clinical Phytoscience 2018; 4(1): 14. [http://dx.doi.org/10.1186/s40816-018-0074-y].
[148]
Reza HM, Tabassum N, Sagor MAT, et al. Angiotensin-converting enzyme inhibitor prevents oxidative stress, inflammation, and fibrosis in carbon tetrachloride-treated rat liver. Toxicol Mech Methods 2016; 26(1): 46-53. [http://dx.doi.org/10.3109/15376516.2015.1124956]. [PMID: 26862777].
[149]
Chowdhury W, Tisha A, Akter S, Zahur S, Hasan N. The role of arsenic on skin diseases, hair fall and inflammation: An immunological review and case studies. J Clin Exp Dermatol Res 2017; 8(384): 2. [http://dx.doi.org/10.4172/2155-9554.1000384].
[150]
You S, Qian J, Sun C, et al. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress. J Cell Mol Med 2018; 22(3): 1931-43. [http://dx.doi.org/10.1111/jcmm.13477]. [PMID: 29327811].
[151]
Meydanli EG, Gumusel A, Ozkan S, et al. Effects of resveratrol on high-fructose-induced testis injury in rats. Ultrastruct Pathol 2018; 42(1): 65-73. [http://dx.doi.org/10.1080/01913123.2017.1397075]. [PMID: 29192848].
[152]
Woodman KG, Coles CA, Toulson SL, et al. Low dose resveratrol promotes hypertrophy in wildtype skeletal muscle and reduces damage in skeletal muscle of exercised mdx mice. bioRxiv 2018; 289587.
[153]
Zhao Y, Song W, Wang Z, et al. Resveratrol attenuates testicular apoptosis in type 1 diabetic mice: Role of Akt-mediated Nrf2 activation and p62-dependent Keap1 degradation. Redox Biol 2018; 14: 609-17. [http://dx.doi.org/10.1016/j.redox.2017.11.007]. [PMID: 29154192].
[154]
de Queiroz KB. Pereira TdSF, Araújo MSS, Gomez RS, Coimbra RS: Resveratrol acts anti-inflammatory and neuroprotective in an infant rat model of pneumococcal meningitis by modulating the hippocampal miRNome. Mol Neurobiol 2018; 1-16.
[155]
Zheng Y, Wu W, Hu G, et al. Hepatic transcriptome analysis of juvenile GIFT tilapia (Oreochromis niloticus), fed diets supplemented with different concentrations of resveratrol. Ecotoxicol Environ Saf 2018; 147: 447-54. [http://dx.doi.org/10.1016/j.ecoenv.2017.08.006]. [PMID: 28892663].
[156]
Wang G, Song X, Zhao L, Li Z, Liu B. Resveratrol prevents diabetic cardiomyopathy by increasing Nrf2 expression and transcriptional activity. BioMed Res Int 2018; 2018: 2150218. [http://dx.doi.org/10.1155/2018/2150218]. [PMID: 29721501].
[157]
García-Alcántara F, Murillo-Cuesta S, Pulido S, et al. The expression of oxidative stress response genes is modulated by a combination of resveratrol and N-acetylcysteine to ameliorate ototoxicity in the rat cochlea. Hear Res 2018; 358: 10-21. [http://dx.doi.org/10.1016/j.heares.2017.12.004]. [PMID: 29304389].
[158]
Swomley AM, Triplett JC, Keeney JT, et al. Comparative proteomic analyses of the parietal lobe from rhesus monkeys fed a high-fat/sugar diet with and without resveratrol supplementation, relative to a healthy diet: Insights into the roles of unhealthy diets and resveratrol on function. J Nutr Biochem 2017; 39: 169-79. [http://dx.doi.org/10.1016/j.jnutbio.2016.10.006]. [PMID: 27840293].
[159]
Bakheet SA, Alzahrani MZ, Ansari MA, et al. AL-Ayadhi LY, Ahmad SF: Resveratrol ameliorates dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in a BTBR T+ tf/J mouse model of autism. Mol Neurobiol 2017; 54(7): 5201-12. [http://dx.doi.org/10.1007/s12035-016-0066-1]. [PMID: 27578011].
[160]
Mohib M, Chowdhury NI, Sarker J, et al. A comprehensive review on effective role of Apple polyphenols in the treatment of obesity, diabetes, and liver dysfunctions with some possible molecular mechanisms. Oxid Antioxid Med Sci 2018; 7(1): 9-27.
[161]
Marzeea AR, Abida T, Salma K, et al. Inhibitory role of resveratrol in the development of profibrogenesis and fibrosis mechanisms. immunology. Endocr Metabol Agents Med Chem 2018; 18(1): 80-104. [http://dx.doi.org/10.2174/1871522218666180523102923].
[162]
Daverey A, Agrawal SK. Pre and post treatment with curcumin and resveratrol protects astrocytes after oxidative stress. Brain Res 2018; 1692: 45-55. [http://dx.doi.org/10.1016/j.brainres.2018.05.001]. [PMID: 29729252].
[163]
Chatterjee K, AlSharif D, Mazza C, Syar P, Al Sharif M, Fata JE. Resveratrol and pterostilbene exhibit anticancer properties involving the downregulation of HPV oncoprotein E6 in cervical cancer cells. Nutrients 2018; 10(2): 243. [http://dx.doi.org/10.3390/nu10020243]. [PMID: 29485619].
[164]
Dragicevic N, Zhang P, Bradshaw P. Synthetic Metalloporphyrins and Resveratrol act synergistically as enhancers of cognitive performance through reduction of deposited amyloid beta and improvement of mitochondrial function in Alzheimer’s mice. Neurology 2017; 88(16 Supplement). : P5-087.
[165]
Jin H, Zhang H, Ma T, et al. Resveratrol protects murine Chondrogenic ATDC5 cells against LPS-induced inflammatory injury through up-regulating MiR-146b. Cell Physiol Biochem 2018; 47(3): 972-80. [http://dx.doi.org/10.1159/000490141]. [PMID: 29843156].
[166]
Dugdale HF, Hughes DC, Allan R, et al. The role of resveratrol on skeletal muscle cell differentiation and myotube hypertrophy during glucose restriction. Mol Cell Biochem 2018; 444(1-2): 109-23. [http://dx.doi.org/10.1007/s11010-017-3236-1]. [PMID: 29189984].
[167]
Liao E, Li Z, Shao Y. Resveratrol regulating SIRT1‐NF‐κB signal pathway in intrahepatic cholestasis of pregnancy. Hepatol Res 2018. [http://dx.doi.org/10.1111/hepr.13198].
[168]
Liu B, Li S, Sui X, et al. Root Extract of Polygonum cuspidatum Siebold & Zucc. Ameliorates DSS-induced ulcerative colitis by affecting NF-kappaB signaling pathway in a mouse model via synergistic effects of polydatin, resveratrol, and emodin. Front Pharmacol 2018; 9: 347. [http://dx.doi.org/10.3389/fphar.2018.00347]. [PMID: 29695964].
[169]
Li Y, Qian W, Wang D, et al. Resveratrol relieves particulate matter (mean diameter< 2.5 μm)‐induced oxidative injury of lung cells through attenuation of autophagy deregulation. J Appl Toxicol 2018. [http://dx.doi.org/10.1002/jat.3636].
[170]
Chu H, Jiang S, Liu Q, et al. Sirtuin1 protects against systemic sclerosis-related pulmonary fibrosis by decreasing proinflammatory and profibrotic processes. Am J Respir Cell Mol Biol 2018; 58(1): 28-39. [http://dx.doi.org/10.1165/rcmb.2016-0192OC]. [PMID: 28800254].
[171]
Thongchot S, Ferraresi A, Vidoni C, et al. Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells. Cancer Lett 2018; 430: 160-71. [http://dx.doi.org/10.1016/j.canlet.2018.05.031]. [PMID: 29802929].
[172]
van der Made SM, Plat J, Mensink RP. Trans-resveratrol supplementation and endothelial function during the fasting and postprandial Phase: A randomized placebo-controlled trial in overweight and slightly obese participants. Nutrients 2017; 9(6): 596. [http://dx.doi.org/10.3390/nu9060596]. [PMID: 28604618].
[173]
Mansur AP, Roggerio A, Goes MFS, et al. Serum concentrations and gene expression of sirtuin 1 in healthy and slightly overweight subjects after caloric restriction or resveratrol supplementation: A randomized trial. Int J Cardiol 2017; 227: 788-94. [http://dx.doi.org/10.1016/j.ijcard.2016.10.058]. [PMID: 28029409].
[174]
Chen S, Zhao X, Ran L, et al. Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial. Dig Liver Dis 2015; 47(3): 226-32. [http://dx.doi.org/10.1016/j.dld.2014.11.015]. [PMID: 25577300].
[175]
Khojah HM, Ahmed S, Abdel-Rahman MS, Elhakeim EH. Resveratrol as an effective adjuvant therapy in the management of rheumatoid arthritis: a clinical study. Clin Rheumatol 2018; 37(8): 2035-42. [http://dx.doi.org/10.1007/s10067-018-4080-8]. [PMID: 29611086].
[176]
Pollack RM, Barzilai N, Anghel V, et al. Resveratrol improves vascular function and mitochondrial number but not glucose metabolism in older adults. J Gerontol A Biol Sci Med Sci 2017; 72(12): 1703-9. [http://dx.doi.org/10.1093/gerona/glx041]. [PMID: 28329397].
[177]
Khodabandehloo H, Seyyedebrahimi S, Esfahani EN, Razi F, Meshkani R. Resveratrol supplementation decreases blood glucose without changing the circulating CD14+CD16+ monocytes and inflammatory cytokines in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study. Nutr Res 2018; 54: 40-51. [http://dx.doi.org/10.1016/j.nutres.2018.03.015]. [PMID: 29914666].
[178]
Malaguarnera G, Pennisi M, Bertino G, et al. Resveratrol in patients with minimal hepatic encephalopathy. Nutrients 2018; 10(3): 329. [http://dx.doi.org/10.3390/nu10030329]. [PMID: 29522439].
[179]
Bardagjy AS, Hu Q, Giebler KA, Ford A, Steinberg FM. Effects of grape consumption on biomarkers of inflammation, endothelial function, and PBMC gene expression in obese subjects. Arch Biochem Biophys 2018; 646: 145-52. [http://dx.doi.org/10.1016/j.abb.2018.04.003]. [PMID: 29649425].
[180]
Khojah HM, Ahmed S, Abdel-Rahman MS, Elhakeim EH. Resveratrol as an effective adjuvant therapy in the management of rheumatoid arthritis: a clinical study. Clin Rheumatol 2018; 37(8): 2035-42. [http://dx.doi.org/10.1007/s10067-018-4080-8]. [PMID: 29611086].
[181]
BoGen H Liu X, Han J. The anti-inflammation effects of resveratrol for patients after oral implantology. Biomed Res 2018; 29(9)
[182]
Lv C, Zhang Y, Shen L. Preliminary clinical effect evaluation of resveratrol in adults with allergic rhinitis. Int Arch Allergy Immunol 2018; 175(4): 231-6. [http://dx.doi.org/10.1159/000486959]. [PMID: 29539616].
[183]
Moussa C, Hebron M, Huang X, et al. Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease. J Neuroinflammation 2017; 14(1): 1. [http://dx.doi.org/10.1186/s12974-016-0779-0]. [PMID: 28086917].
[184]
Bo S, Ponzo V, Evangelista A, et al. Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial. Acta Diabetol 2017; 54(5): 499-507. [http://dx.doi.org/10.1007/s00592-017-0977-y]. [PMID: 28238190].
[185]
Bo S, Togliatto G, Gambino R, et al. Impact of sirtuin-1 expression on H3K56 acetylation and oxidative stress: a double-blind randomized controlled trial with resveratrol supplementation. Acta Diabetol 2018; 55(4): 331-40. [http://dx.doi.org/10.1007/s00592-017-1097-4]. [PMID: 29330620].
[186]
Wong RHX, Evans HM, Howe PRC. Resveratrol supplementation reduces pain experience by postmenopausal women. Menopause 2017; 24(8): 916-22. [http://dx.doi.org/10.1097/GME.0000000000000861]. [PMID: 28350759].
[187]
Seyyedebrahimi S, Khodabandehloo H, Nasli Esfahani E, Meshkani R. The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial. Acta Diabetol 2018; 55(4): 341-53. [http://dx.doi.org/10.1007/s00592-017-1098-3]. [PMID: 29357033].
[188]
Samsamikor M, Daryani NE, Asl PR, Hekmatdoost A. Resveratrol supplementation and oxidative/anti-oxidative status in patients with ulcerative colitis: A randomized, double-blind, placebo-controlled pilot study. Arch Med Res 2016; 47(4): 304-9. [http://dx.doi.org/10.1016/j.arcmed.2016.07.003]. [PMID: 27664491].
[189]
Shi G, Hua M, Xu Q, Ren T. Resveratrol improves treatment outcome and laboratory parameters in patients with Takayasu arteritis: A randomized double-blind and placebo-controlled trial. Immunobiology 2017; 222(2): 164-8. [http://dx.doi.org/10.1016/j.imbio.2016.10.008]. [PMID: 27771172].
[190]
Farooqi AA, Khalid S, Ahmad A. Regulation of cell signaling pathways and miRNAs by resveratrol in different cancers. Int J Mol Sci 2018; 19(3): 652. [http://dx.doi.org/10.3390/ijms19030652]. [PMID: 29495357].
[191]
Polakis P. Wnt signaling in cancer. Cold Spring Harb Perspect Biol 2012; 4(5): a008052. [http://dx.doi.org/10.1101/cshperspect.a008052]. [PMID: 22438566].
[192]
Liu ZL, Li H, Liu J, et al. Inactivated Wnt signaling in resveratrol-treated epidermal squamous cancer cells and its biological implication. Oncol Lett 2017; 14(2): 2239-43. [http://dx.doi.org/10.3892/ol.2017.6458]. [PMID: 28781663].
[193]
Liu C-y, Yen H-y, Tsao C-W, Su H-Y, Lin Y-W. Resveratrol inhibits ovarian cancer cell growth through epigenetic regulation of Wnt antogonist SFRP5. FASEB J 2017; 31(1_supplement). : 790-10.
[194]
Dai H, Deng H-B, Wang Y-H, Guo J-J. Resveratrol inhibits the growth of gastric cancer via the Wnt/β-catenin pathway. Oncol Lett 2018; 16(2): 1579-83. [http://dx.doi.org/10.3892/ol.2018.8772]. [PMID: 30008840].
[195]
Xie D, Zheng G-Z, Xie P, et al. Antitumor activity of resveratrol against human osteosarcoma cells: a key role of Cx43 and Wnt/β-catenin signaling pathway. Oncotarget 2017; 8(67): 111419-32. [http://dx.doi.org/10.18632/oncotarget.22810]. [PMID: 29340064].
[196]
Cheah FK, Leong KH, Thomas NF, Chin HK, Ariffin A, Awang K. Resveratrol analogue, (E)-N-(2-(4-methoxystyryl) phenyl) furan-2-carboxamide induces G2/M cell cycle arrest through the activation of p53-p21CIP1/WAF1 in human colorectal HCT116 cells. Apoptosis 2018; 23(5-6): 329-42. [http://dx.doi.org/10.1007/s10495-018-1457-8]. [PMID: 29754265].
[197]
Zhang L, Wen X, Li M, Li S, Zhao H. Targeting cancer stem cells and signaling pathways by resveratrol and pterostilbene. Biofactors 2018; 44(1): 61-8. [http://dx.doi.org/10.1002/biof.1398]. [PMID: 29205560].
[198]
Peitzsch C, Tyutyunnykova A, Pantel K, Dubrovska A. Cancer stem cells: the root of tumor recurrence and metastases. Seminars in cancer biology: 2017 Elsevier 2017; 10-24.
[http://dx.doi.org/10.1016/j.semcancer.2017.02.011]
[199]
Pandey PR, Okuda H, Watabe M, et al. Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase. Breast Cancer Res Treat 2011; 130(2): 387-98. [http://dx.doi.org/10.1007/s10549-010-1300-6]. [PMID: 21188630].


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 25
ISSUE: 12
Year: 2019
Page: [1345 - 1371]
Pages: 27
DOI: 10.2174/1381612825666190410153307
Price: $58

Article Metrics

PDF: 33
HTML: 3

Special-new-year-discount